Latest Talk
Gene and Cell Therapy – An Overview of the Current and Changing Regulatory
Mark D. Johnson, MS; Scott E. Boley, PhD, DABT
Gene and Cell Therapy – An Overview of the Current and Changing Regulatory Requirements and Study Design for Nonclinical Safety Evaluation Nonclinical development of gene and cell therapies has been ongoing for more than three decades, and has been increasing in recent years. In the early days of these efforts, these therapies shared the fate…
